FULVESTRANT INJECTION
Google image searchProduct monograph
Active ingredient
fulvestrant, 50 MG/ML
DIN: 02486792
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Schedule: Prescription
Company: ACCORD HEALTHCARE INC
Date: 02-MAR-2022
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BA — Anti-estrogens (ATC, ATC/DDD)
- L02BA03 — FULVESTRANT (ATC/DDD)
Reference brand drug: Faslodex
